Crossmark

Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand

Crossref DOI link: https://doi.org/10.1007/s40256-018-0288-x

Published Online: 2018-06-21

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Krittayaphong, Rungroj

Permsuwan, Unchalee
License Information

Text and Data Mining valid from 2018-06-21
More Information

Article History

First Online: 21 June 2018

Compliance with Ethical Standards

:

: No sources of funding were used to conduct this study or prepare this manuscript.

: Rungroj Krittayaphong and Unchalee Permsuwan have no conflicts of interest that are directly relevant to the content of this study.

: This project did not involve the study of human subjects or animals.